| Line 168: |
Line 168: |
| | ==CLAN== | | ==CLAN== |
| | ===Alpha entrainment analgesia study=== | | ===Alpha entrainment analgesia study=== |
| − | *How to leverage Ripple hardware/BATMAN (lab-grade, non-FDA approved device) to entrain or modulate alpha band? | + | *Successfully entrain alpha. |
| − | **Successfully entrain alpha. What were we doing wrong? '''Is there anything in the literature that can guide a protocol modification?''' | + | **What were we doing wrong? |
| − | **Can I incorporate pain/withdrawal thresholds since everyone's pain tolerance might be different.
| + | **'''Is there anything in the literature that can guide a protocol modification?''' |
| − | **Make it multi-center
| |
| − | **'''Is alpha dropout selective for certain types of pain?'''
| |
| − | **Power analysis based on pilot study
| |
| | **'''Systematic review and meta analysis''' | | **'''Systematic review and meta analysis''' |
| − | **Stimulation of inhibitory neurons in the ACC expressing channelrhodopsin-2 resulted in a reduction of reflexive acute pain responses in mice. | + | **Can we leverage Ripple hardware/BATMAN (lab-grade, non-FDA approved device) to entrain or modulate alpha band? |
| | + | *Can I incorporate pain/withdrawal thresholds since everyone's pain tolerance might be different. |
| | + | *Make it multi-center |
| | + | *'''Is alpha dropout selective for certain types of pain?''' |
| | + | *Power analysis based on pilot study |
| | + | *Stimulation of inhibitory neurons in the ACC expressing channelrhodopsin-2 resulted in a reduction of reflexive acute pain responses in mice. |
| | ====EEG nociceptive signatures==== | | ====EEG nociceptive signatures==== |
| | *See Naloxone below for a start. | | *See Naloxone below for a start. |